| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina USA 27709
The mechanisms responsible for the broad spectrum of effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) are not entirely clear but seem to involve an initial interaction with the Ah receptor. A major uncertainty in risk assessment for TCDD is the lack of adequate dose-response relationships following chronic exposure to TCDD. Induction of cytochrome P-450 enzymes (CYP1A1 and CYP1A2) is one of the most sensitive responses to TCDD and its structural analogues. We have used a two-stage model for hepatocarcinogenesis in female Sprague-Dawley rats to evaluate dose-response relationships for induction of CYP1A1 and CYP1A2 in diethylnitrosamine-initiated as well as in noninitiated rats. After initiation with a single dose of diethylnitrosamine, TCDD was administered biweekly by p.o. gavage at doses equivalent to 3.5, 10.7, 35.7, and 125 ng/kg/day for 30 weeks. CYP1A1 and CYP1A2 concentrations were quantified in hepatic microsomes by radioimmunoassay and localized in hepatic tissue slices by immunohistochemical techniques. Radioimmunoassay data revealed a maximum induction of 200-fold for CYP1A1 and 10-fold for CYP1A2 and there were no statistically significant differences between initiated and noninitiated rats. Induction at the lowest dose (3.5 ng/kg/day) was 20-fold for CYP1A1 and 3-fold for CYP1A2. Mathematical analysis indicates that the best fit of the induction data are inconsistent with a threshold for this response. There was a linear relationship between administered dose and TCDD liver concentration over the entire dose range of the study. This indicates that induction of CYP1A2 does not significantly alter the distribution of TCDD in our chronic dosing regimen. Immunolocalization of CYP1A1 and CYP1A2 revealed the same localization and induction pattern for both isozymes in the cytoplasm of hepatocytes. However, the hepatic distribution pattern was not uniform with the most intense staining observed around central veins. These studies help to clarify dose-response relationships for dioxin-mediated effects and demonstrate different sensitivity of hepatocytes to the effects of TCDD.
1 To whom requests for reprints should be addressed, at NIEHS, MD D4-01, P. O. Box 12233, Research Triangle Park, NC 27709.
Received 12/26/91. Accepted 4/ 7/92.
This article has been cited by other articles:
|
|
 |
|
  D.-H. Lee, D. R Jacobs Jr, and M. Porta Could low-level background exposure to persistent organic pollutants contribute to the social burden of type 2 diabetes? J. Epidemiol. Community Health, December 1, 2006; 60(12): 1006 - 1008. [Full Text] [PDF]
|
|
|
|
 |
|
 D.-H. Lee, I.-K. Lee, K. Song, M. Steffes, W. Toscano, B. A. Baker, and D. R. Jacobs Jr A Strong Dose-Response Relation Between Serum Concentrations of Persistent Organic Pollutants and Diabetes: Results from the National Health and Examination Survey 1999-2002 Diabetes Care, July 1, 2006; 29(7): 1638 - 1644. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. J. Broccardo, R. E. Billings, M. E. Andersen, and W. H. Hanneman Probing the Control Elements of the CYP1A1 Switching Module in H4IIE Hepatoma Cells Toxicol. Sci., November 1, 2005; 88(1): 82 - 94. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. B. Silkworth, A. Koganti, K. Illouz, A. Possolo, M. Zhao, and S. B. Hamilton Comparison of TCDD and PCB CYP1A Induction Sensitivities in Fresh Hepatocytes from Human Donors, Sprague-Dawley Rats, and Rhesus Monkeys and HepG2 Cells Toxicol. Sci., October 1, 2005; 87(2): 508 - 519. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. SLIKKER JR., J. F. YOUNG, R. A. CORLEY, D. C. DORMAN, R. B. CONOLLY, T. B. KNUDSEN, B. L. ERSTAD, R. H. LUECKE, E. M. FAUSTMAN, C. TIMCHALK, et al. Improving Predictive Modeling in Pediatric Drug Development: Pharmacokinetics, Pharmacodynamics, and Mechanistic Modeling Ann. N.Y. Acad. Sci., August 1, 2005; 1053(1): 505 - 518. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Nishimura, J. Yonemoto, H. Nishimura, S.-i. Ikushiro, and C. Tohyama Disruption of Thyroid Hormone Homeostasis at Weaning of Holtzman Rats by Lactational but Not In Utero Exposure to 2,3,7,8-Tetrachlorodibenzo-p-Dioxin Toxicol. Sci., May 1, 2005; 85(1): 607 - 614. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. S. Chubb, M. E. Andersen, C. J. Broccardo, M. E. Legare, R. E. Billings, C. E. Dean, and W. H. Hanneman Regional Induction of CYP1A1 in Rat Liver Following Treatment with Mixtures of PCB 126 and PCB 153 Toxicol Pathol, June 1, 2004; 32(4): 467 - 473. [Abstract] [PDF]
|
|
|
|
|
|
C. J. Broccardo, R. E. Billings, L. S. Chubb, M. E. Andersen, and W. H. Hanneman Single Cell Analysis of Switch-Like Induction of CYP1A1 in Liver Cell Lines Toxicol. Sci., April 1, 2004; 78(2): 287 - 294. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. T. French, W. H. Hanneman, L. S. Chubb, R. E. Billings, and M. E. Andersen Induction of CYP1A1 in Primary Rat Hepatocytes by 3,3',4,4',5-Pentachlorobiphenyl: Evidence for a Switch Circuit Element Toxicol. Sci., April 1, 2004; 78(2): 276 - 286. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Sarangapani, J. Teeguarden, K. P. Plotzke, J. M. McKim Jr., and M. E. Andersen Dose-Response Modeling of Cytochrome P450 Induction in Rats by Octamethylcyclotetrasiloxane Toxicol. Sci., June 1, 2002; 67(2): 159 - 172. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. P. Bofinger, L. Feng, L.-H. Chi, J. Love, F. D. Stephen, T. R. Sutter, K. G. Osteen, T. G. Costich, R. E. Batt, S. T. Koury, et al. Effect of TCDD Exposure on CYP1A1 and CYP1B1 Expression in Explant Cultures of Human Endometrium Toxicol. Sci., August 1, 2001; 62(2): 299 - 314. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. Diliberto, M. J. DeVito, D. G. Ross, and L. S. Birnbaum Subchronic Exposure of [3H]-2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) in Female B6C3F1 Mice: Relationship of Steady-State Levels to Disposition and Metabolism Toxicol. Sci., June 1, 2001; 61(2): 241 - 255. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Tritscher, J. Mahler, C. J. Portier, G. W. Lucier, and N. J. Walker Induction of Lung Lesions in Female Rats Following Chronic Exposure to 2,3,7,8-Tetrachlorodibenzo-p-dioxin Toxicol Pathol, November 1, 2000; 28(6): 761 - 769. [Abstract] [PDF]
|
|
|
|
|
|
B. P. Slezak, G. E. Hatch, M. J. DeVito, J. J. Diliberto, R. Slade, K. Crissman, E. Hassoun, and L. S. Birnbaum Oxidative Stress in Female B6C3F1 Mice following Acute and Subchronic Exposure to 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) Toxicol. Sci., April 1, 2000; 54(2): 390 - 398. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. E. Burczynski and T. M. Penning Genotoxic Polycyclic Aromatic Hydrocarbon ortho-Quinones Generated by Aldo-Keto Reductases Induce CYP1A1 via Nuclear Translocation of the Aryl Hydrocarbon Receptor Cancer Res., February 1, 2000; 60(4): 908 - 915. [Abstract] [Full Text]
|
|
|
|
|
|
L. EDLER Uncertainty in Biomonitoring and Kinetic Modeling Ann. N.Y. Acad. Sci., January 1, 1999; 895(1): 80 - 100. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. E Andersen and R. B Conolly Mechanistic modeling of rodent liver tumor promotion at low levels of exposure: an example related to dose-response relationships for 2,3,7,8-tetrachlorodibenzo-p-dioxin Human and Experimental Toxicology, December 1, 1998; 17(12): 683 - 690. [PDF]
|
|
|
|
 |
|
 P. R. Sinclair, N. Gorman, H. S. Walton, J. F. Sinclair, C. A. Lee, and A. B. Rifkind Identification of CYP1A5 as the CYP1A Enzyme Mainly Responsible for Uroporphyrinogen Oxidation Induced by Ah Receptor Ligands in Chicken Liver and Kidney Drug Metab. Dispos., July 1, 1997; 25(7): 779 - 783. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
